Literature DB >> 1686014

Molecular mapping of the mouse ob mutation.

J M Friedman1, R L Leibel, D S Siegel, J Walsh, N Bahary.   

Abstract

The mouse ob mutation has been mapped relative to a series of RFLPs among the progeny of three separate mouse crosses: an intraspecific backcross, an intraspecific intercross, and an interspecific intercross. Genotypic assignment at the ob locus was made by making use of measurements of body mass index and the plasma concentrations of glucose and insulin. These data have suggested that the development of diabetes in these animals is a consequence of unlinked polygenes. There was also evidence that unlinked Mus spretus alleles can diminish the obesity of ob/ob mice. From these data we have mapped several markers on chromosome 6 with the following order: cen-Cola-2-Met-ob-Cpa-Tcrb. The homologs of markers that flank ob map to human chromosome 7q, suggesting that if there is a human homologue of ob, it maps to 7q31.

Entities:  

Mesh:

Year:  1991        PMID: 1686014     DOI: 10.1016/0888-7543(91)90032-a

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  42 in total

Review 1.  Mouse chromosome 6.

Authors:  R W Elliott; K J Moore
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

2.  Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice.

Authors:  Xiaokun Ding; Neeraj K Saxena; Songbai Lin; Nitika Arora Gupta; Narita Gupta; Frank A Anania
Journal:  Hepatology       Date:  2006-01       Impact factor: 17.425

Review 3.  Relevance of animal models to human eating disorders and obesity.

Authors:  Regina C Casper; Elinor L Sullivan; Laurence Tecott
Journal:  Psychopharmacology (Berl)       Date:  2008-03-04       Impact factor: 4.530

4.  Enhanced sensitivity to CD95-induced apoptosis in ob/ob mice.

Authors:  Juergen Siebler; Markus Schuchmann; Susanne Strand; Hans A Lehr; Markus F Neurath; Peter R Galle
Journal:  Dig Dis Sci       Date:  2007-04-06       Impact factor: 3.199

5.  Targeting the IKKβ/mTOR/VEGF signaling pathway as a potential therapeutic strategy for obesity-related breast cancer.

Authors:  Chun-Te Chen; Yi Du; Hirohito Yamaguchi; Jung-Mao Hsu; Hsu-Ping Kuo; Gabriel N Hortobagyi; Mien-Chie Hung
Journal:  Mol Cancer Ther       Date:  2012-07-23       Impact factor: 6.261

6.  Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma.

Authors:  P De Vos; A M Lefebvre; S G Miller; M Guerre-Millo; K Wong; R Saladin; L G Hamann; B Staels; M R Briggs; J Auwerx
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

7.  Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression.

Authors:  Eek Joong Park; Jun Hee Lee; Guann-Yi Yu; Guobin He; Syed Raza Ali; Ryan G Holzer; Christoph H Osterreicher; Hiroyuki Takahashi; Michael Karin
Journal:  Cell       Date:  2010-01-22       Impact factor: 41.582

8.  The adipocyte specific transcription factor C/EBPalpha modulates human ob gene expression.

Authors:  S G Miller; P De Vos; M Guerre-Millo; K Wong; T Hermann; B Staels; M R Briggs; J Auwerx
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

9.  OB protein binds specifically to the choroid plexus of mice and rats.

Authors:  R Devos; J G Richards; L A Campfield; L A Tartaglia; Y Guisez; J van der Heyden; J Travernier; G Plaetinck; P Burn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

10.  C/EBPbeta regulates body composition, energy balance-related hormones and tumor growth.

Authors:  Jennifer Staiger; Mary J Lueben; David Berrigan; Radek Malik; Susan N Perkins; Stephen D Hursting; Peter F Johnson
Journal:  Carcinogenesis       Date:  2008-12-04       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.